CEI
Clark Estates Inc Portfolio holdings
AUM
$446M
1-Year Est. Return
6.99%
1 Year Est. Return
+6.99%
AUM
$446M
AUM Growth
-$26.6M
(-5.6%)
Holding
108
Top Buys
| 1 | +$15.5M | |
| 2 | +$9.46M | |
| 3 | +$7.76M | |
| 4 |
United Parks & Resorts
PRKS
|
+$6.13M |
| 5 |
Bausch + Lomb
BLCO
|
+$2.97M |
Top Sells
| 1 | +$23.9M | |
| 2 | +$7.98M | |
| 3 | +$7.04M | |
| 4 |
Smith & Nephew
SNN
|
+$5.36M |
| 5 |
Sony
SONY
|
+$5.21M |
Sector Composition
| 1 | Healthcare | 36.1% |
| 2 | Consumer Staples | 12.26% |
| 3 | Technology | 11.71% |
| 4 | Communication Services | 7.47% |
| 5 | Consumer Discretionary | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Euclidean Fundamental Value ETF
ECML
$131M
| $95M | 21.32% |
3,085,507
-66,189
|
|
||
2
IQVIA
IQV
$35B
| $24.5M | 5.49% |
155,200
+60,000
|
|
||
3
Baxter International
BAX
$11.8B
| $24.4M | 5.47% |
805,000
+55,000
|
|
||
4
Medtronic
MDT
$122B
| $21.8M | 4.89% |
250,000
|
|
||
|
5
Smith & Nephew
SNN
$15.2B
| $20.7M | 4.64% |
675,000
-175,000
|
|
||
6
Kenvue
KVUE
$27.1B
| $18.8M | 4.23% |
900,000
+50,000
|
|
||
7
Haleon
HLN
$41B
| $18.7M | 4.19% |
1,800,000
-200,000
|
|
||
8
Walt Disney
DIS
$198B
| $15.5M | 3.48% |
+125,000
|
|
||
9
Diageo
DEO
$54.8B
| $14.6M | 3.28% |
145,000
-40,000
|
|
||
10
Fiserv
FI
$64.1B
| $12.1M | 2.72% |
70,300
+45,000
|
|
||
|
11
Bausch + Lomb
BLCO
$5.26B
| $11.1M | 2.48% |
850,000
+228,000
|
|
||
12
Unilever
UL
$152B
| $11M | 2.47% |
180,000
-55,000
|
|
||
|
13
Sony
SONY
$170B
| $10.4M | 2.34% |
400,000
-200,000
|
|
||
|
14
United Parks & Resorts
PRKS
$2.87B
| $6.13M | 1.38% |
+130,000
|
|
||
15
Avanos Medical
AVNS
$532M
| $6.05M | 1.36% |
493,880
|
|
||
16
Heidrick & Struggles
HSII
$1.21B
| $3.08M | 0.69% |
67,387
|
|
||
17
Indivior
INDV
$3.08B
| $3M | 0.67% |
203,600
+17,325
|
|
||
18
Gilead Sciences
GILD
$146B
| $2.89M | 0.65% |
26,022
|
|
||
19
Altria Group
MO
$108B
| $2.85M | 0.64% |
48,613
|
|
||
20
Nextracker
NXT
$13B
| $2.71M | 0.61% |
49,818
-8,800
|
|
||
21
John Wiley & Sons Class A
WLY
$1.97B
| $2.56M | 0.57% |
57,252
|
|
||
22
Catalyst Pharmaceutical
CPRX
$2.51B
| $2.47M | 0.55% |
113,918
-20,500
|
|
||
23
Pediatrix Medical
MD
$1.41B
| $2.46M | 0.55% |
171,313
-33,300
|
|
||
24
Resideo Technologies
REZI
$6.16B
| $2.41M | 0.54% |
109,100
|
|
||
25
Incyte
INCY
$17B
| $2.38M | 0.53% |
34,952
|
|